Three-Step Synthesis of the Antiepileptic Drug Candidate Pynegabine
Pynegabine, an antiepileptic drug candidate in phase I clinical trials, is a structural analog of the marketed drug retigabine with improved chemical stability, strong efficacy, and a better safety margin. The reported shortest synthetic route for pynegabine contains six steps and involves the manip...
Main Authors: | Yi-Jing Sun, Ya-Ling Gong, Shi-Chao Lu, Shi-Peng Zhang, Shu Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/13/4888 |
Similar Items
-
Synthesis and cytotoxicity studies of novel N-arylbenzo[h]quinazolin-2-amines
by: Battini Veeraiah, et al.
Published: (2024-10-01) -
Stabilized Palladium Nanoparticles from Bis-(<i>N</i>-benzoylthiourea) Derived-Pd<sup>II</sup> Complexes as Efficient Catalysts for Sustainable Cross-Coupling Reactions in Water
by: Samet Poyraz, et al.
Published: (2024-03-01) -
<i>N</i>,<i>N</i>-Bis(4′-(hexyloxy)-[1,1′-biphenyl]-4-yl)thiophen-2-amine
by: Timofey N. Chmovzh, et al.
Published: (2021-10-01) -
Probing the origin of higher efficiency of terphenyl phosphine over the biaryl framework in Pd-catalyzed C-N coupling: A combined DFT and machine learning study
by: Qingfu Ye, et al.
Published: (2023-06-01) -
New antibacterial, antifungal and antioxidant agents bearing sulfonamide
by: Regina Chinelo Ochu, et al.
Published: (2024-04-01)